The Effect of Intravitreal Triamcinolone Acetonide Injection according to the Diabetic Macular Edema Type.
- Author:
Young Gun KIM
1
;
Seung Young YU
;
Hyung Woo KWAK
Author Information
1. Department of Ophthalmology, Kyung Hee University Hospital, Seoul, Korea. hwkwak@khmc.or.kr
- Publication Type:Original Article
- Keywords:
Intravitreal injection;
Macular edema;
Triamcinolone acetonide
- MeSH:
Humans;
Intravitreal Injections;
Macular Edema*;
Porifera;
Prospective Studies;
Tomography, Optical Coherence;
Triamcinolone Acetonide*;
Triamcinolone*;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2005;46(1):84-89
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To determine if intravitreal injection of triamcinolone acetonide (IVTA) is effective for diabetic macular edema according to the type of macular edema. METHODS: This prospective, clinical series study was carried out on 31 eyes with diabetic macular edema, which had received an intravitreal injection of 4 mg of triamcinolone acetonide. We analyzed the visual acuity and foveal thickness at post-treatment 1 week, 1, 3, and 6 months according to the type of diabetic macular edema by optical coherence tomography (OCT). RESULTS: OCT showed 3 patterns of macular edema: cystoid type (18 eyes), sponge type (7 eyes), and serous detachment type (6 eyes). Visual acuity and foveal thickness improved in all patients. The cystoid types of macular edema show better response than the other types in visual acuity and foveal thickness. CONCLUSIONS: IVTA is a good therapeutic options for diabetic macular edema. IVTA is more effective in cystoid macular edema. Furthermore, study with more patients and focal laser treatment according to the type of macular edema may be necessary for further evaluation.
